Indies Pharma Jamaica Statistics

Total Valuation

Indies Pharma Jamaica has a market cap or net worth of JMD 4.58 billion. The enterprise value is 5.22 billion.

Market Cap	4.58B
Enterprise Value	5.22B

Important Dates

The last earnings date was Friday, December 13, 2024.

Earnings Date	Dec 13, 2024
Ex-Dividend Date	Jul 15, 2024

Share Statistics

Indies Pharma Jamaica has 1.33 billion shares outstanding. The number of shares has decreased by -0.01% in one year.

Current Share Class	n/a
Shares Outstanding	1.33B
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	-9.43%
Owned by Insiders (%)	5.77%
Owned by Institutions (%)	9.04%
Float	247.71M

Valuation Ratios

The trailing PE ratio is 20.72.

PE Ratio	20.72
Forward PE	n/a
PS Ratio	3.95
PB Ratio	3.54
P/TBV Ratio	5.51
P/FCF Ratio	18.89
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.17, with an EV/FCF ratio of 21.50.

EV / Earnings	23.59
EV / Sales	4.50
EV / EBITDA	14.17
EV / EBIT	17.00
EV / FCF	21.50

Financial Position

The company has a current ratio of 7.13, with a Debt / Equity ratio of 0.66.

Current Ratio	7.13
Quick Ratio	4.32
Debt / Equity	0.66
Debt / EBITDA	2.32
Debt / FCF	3.52
Interest Coverage	4.81

Financial Efficiency

Return on equity (ROE) is 17.60% and return on invested capital (ROIC) is 8.98%.

Return on Equity (ROE)	17.60%
Return on Assets (ROA)	8.45%
Return on Capital (ROIC)	8.98%
Revenue Per Employee	16.32M
Profits Per Employee	3.12M
Employee Count	71
Asset Turnover	0.51
Inventory Turnover	1.83

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.77% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+8.77%
50-Day Moving Average	3.12
200-Day Moving Average	2.81
Relative Strength Index (RSI)	58.54
Average Volume (20 Days)	64,883

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Indies Pharma Jamaica had revenue of JMD 1.16 billion and earned 221.18 million in profits. Earnings per share was 0.17.

Revenue	1.16B
Gross Profit	774.67M
Operating Income	306.79M
Pretax Income	251.77M
Net Income	221.18M
EBITDA	326.97M
EBIT	306.79M
Earnings Per Share (EPS)	0.17

Full Income Statement

Balance Sheet

The company has 221.97 million in cash and 854.99 million in debt, giving a net cash position of -633.02 million or -0.48 per share.

Cash & Cash Equivalents	221.97M
Total Debt	854.99M
Net Cash	-633.02M
Net Cash Per Share	-0.48
Equity (Book Value)	1.29B
Book Value Per Share	0.97
Working Capital	672.08M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 245.45 million and capital expenditures -2.76 million, giving a free cash flow of 242.68 million.

Operating Cash Flow	245.45M
Capital Expenditures	-2.76M
Free Cash Flow	242.68M
FCF Per Share	0.18

Full Cash Flow Statement

Margins

Gross margin is 66.84%, with operating and profit margins of 26.47% and 19.08%.

Gross Margin	66.84%
Operating Margin	26.47%
Pretax Margin	21.72%
Profit Margin	19.08%
EBITDA Margin	28.21%
EBIT Margin	26.47%
FCF Margin	20.94%

Dividends & Yields

This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 3.20%.

Dividend Per Share	0.11
Dividend Yield	3.20%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	66.27%
Buyback Yield	0.01%
Shareholder Yield	3.21%
Earnings Yield	4.83%
FCF Yield	5.29%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Indies Pharma Jamaica has an Altman Z-Score of 3.86.

Altman Z-Score	3.86
Piotroski F-Score	n/a